MCI Capital Commences Tender Offer To Purchase Up To 1.53 Mln Of Atento Shares At $5.00/shr In Cash

Atento S.A. (ATTO) confirmed that on November 18, 2022, MCI Capital LC commenced a tender offer to purchase up to 1.53 million of the company's ordinary shares at a price of $5.00 per share in cash.

ATTO closed Monday regular trading at $7.00 up $1.32 or 23.24%.

The company said that it is evaluating the Tender Offer and determining whether it will recommend that stockholders accept or reject the Tender Offer, or whether it expresses no opinion and remains neutral toward the Tender Offer.

The company will notify stockholders of the Board's formal recommendation on or before December 5, 2022.

The company's stockholders are advised to take no action at this time pending the review of the Tender Offer by the Board.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT